Physician profile
Katee E Castleman
NPI 1902244320
$1,124.36
in general payments reported to CMS, 2019-2025
16 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $25.46 · 2021: $183 · 2022: $36.32 · 2023: $263 · 2024: $146 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $594.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $295.04 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $175.01 | 2019 | |
| Neurocrine Biosciences, INC. | $128.09 | 2023 | Ingrezza |
| Novartis Pharmaceuticals Corporation | $67.88 | 2019-2023 | |
| Stryker Corporation | $64.69 | 2025 | Flowtriever |
| Janssen Pharmaceuticals, INC | $60.41 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $59.98 | 2020-2023 | Lokelma |
| Pfizer INC. | $58.65 | 2019-2024 | |
| Abiomed | $45.31 | 2025 | |
| Recor Medical INC | $33.54 | 2025 | Paradise Ultrasound Renal Denervation System |
| Shionogi INC | $32.01 | 2024 | Fetroja |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.09 | 2024 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.07 | 2025 | Xifaxan |
| Atricure, INC. | $21.99 | 2024 | |
| Smith+Nephew, INC. | $18.14 | 2025 | Collagenase Santyl |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $15.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katee Castleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.